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Abstract
Genome-wide association studies have identiﬁed over 100 robust risk loci for schizophrenia with thousands of variants
mediating genetic heritability, the majority of which reside in non-coding regions. Analytical approaches have shown
this heritability is strongly enriched at variants within regulatory elements identiﬁed from human post-mortem brain
tissue. However, bulk post-mortem brain tissue has a heterogeneous cell composition, making biological
interpretations difﬁcult. We sought to reﬁne the cell types mediating schizophrenia heritability by separating neuronal
and glial signals using data from: (1) NeuN-sorted post-mortem brain and (2) cell culture systems. Schizophrenia
heritability was partitioned using linkage disequilbrium (LD) score regression. Variants within genomic regions marked
by H3K4me3 (marker of active promoters) from NeuN-positive (neuronal) and NeuN-negative (non-neuronal) cells
explained a signiﬁcant amount of schizophrenia heritability (P = 1.38 × 10−10 and P = 7.97 × 10−10). However, variants
located in H3K4me3 sites speciﬁc to NeuN-positive (neuronal) cells were enriched (P = 3.13 × 10−4), while those speciﬁc
to NeuN-negative (non-neuronal) cells were not (P = 0.470). Data from cell culture systems mimicked this pattern of
association. We show the previously observed enrichment of heritability from variants at brain H3K4me3 sites is
mediated by both neuronal and non-neuronal brain cell types. However, only neuronal cell populations showed a
unique contribution driven by cell-type speciﬁc regulatory elements. Cell culture systems recapitulate disease relevant
gene-regulatory landscapes, validating them as a tool for future investigation of genetic mechanisms underlying
schizophrenia. Identifying the cell types in which risk variants operate will greatly increase our understanding of
schizophrenia pathobiology and aid in the development of novel model systems and therapies.
Introduction
Genome-wide association studies (GWAS) have suc-
cessfully identiﬁed genetic loci mediating human diseases
and phenotypes. For schizophrenia, more than 100
genome-wide signiﬁcant loci have been identiﬁed1.
Although individual variants weakly inﬂuence disease risk,
collectively common variants, including those that do not
yet reach statistical signiﬁcance, explain a substantial
proportion of the heritability of schizophrenia2,3.
Consistent with the genetic architecture of other common
complex disorders, the majority of risk variants are loca-
ted within non-coding regions of the genome, suggesting
that they alter risk by changing levels of gene expression
and/or splicing. Mechanistically, causal variants will dis-
rupt the function of non-coding regulatory elements in
cell types relevant to disease. Similarly, although the
heritability of complex diseases is governed by thousands
of variants across the genome, it is enriched at regulatory
elements from speciﬁc cell types4. These measurements of
partitioned heritability, as well as other enrichment ana-
lyses5, can provide powerful insights into the tissue and
cell types underlying pathobiology, which are important
for establishing valid disease models and assays of gene
function.
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Several large-scale projects (e.g. ENCODE6, Epigenetics
Roadmap7, BLUEPRINT8) have begun to map the reg-
ulatory landscape of different human cell and tissue types.
Using these data it has been shown that schizophrenia
heritability is most strongly enriched at variants within
regulatory regions identiﬁed in post-mortem brain tissue4,
particularly those marked by the histone modiﬁcation
H3K4me3, a modiﬁcation enriched at active gene pro-
moters9. However, the brain is composed of many dif-
ferent cells types, making biological interpretation of
these results difﬁcult. A fuller understanding of disease
risk mechanisms will require detailed analysis of speciﬁc
cell types, developmental stages and physiological
contexts.
The broadest subdivision of brain cell types is the
separation of neurons and glia. We sought to investigate
the relative importance of these two major cell popula-
tions in mediating schizophrenia genetic risk. Given that a
large number of variants inﬂuence genetic risk for schi-
zophrenia, including those outside genome-wide sig-
niﬁcant loci, we selected to use measurements of
heritability that incorporate genome-wide data. Firstly, we
partitioned the heritability of schizophrenia from the
latest GWAS available from the Psychiatric Genomics
Consortium using epigenomic data from NeuN-sorted
post-mortem brain cells, and secondly, using epigenomic
data from cultured human neurons and astrocytes. In
doing so, we also investigated the validity of cell culture
systems, including human stem cell-derived neurons, as
tools for understanding schizophrenia genetic risk
mechanisms.
Methods
Chromatin immunoprecipitation-sequencing data sets and
processing
H3K4me3 chromatin immunoprecipitation (ChIP)-
sequencing data from human embryonic stem cell-
derived neurons were generated by the Epigenomics
Roadmap7. Preprocessed broad peak calls for H3K4me3
were downloaded from http://egg2.wustl.edu/roadmap/
data/byFileType/peaks/consolidated/broadPeak/. Peaks
with a negative log10 P-value of 5 or greater were retained
for further analysis, as described in the original MACS
protocol10.
H3K4me3 ChIP-sequencing data from NeuN-positive
and NeuN-sorted human post-mortem brain nuclei11
(GEO accession numbers: GSM529964, GSM529969,
GSM529971 and GSM529972) were downloaded from the
Sequence Read Archive (SRA, accession number:
GSE21172). These data correspond to chromatin immu-
noprecipitation (ChIP) experiments performed on two
donor samples, for which both NeuN-positive and NeuN-
negative sorted cell populations were available. SRA ﬁles
were converted to fastq ﬁles using fastq-dump, part of the
SRA toolkit available from NCBI (http://www.ncbi.nlm.
nih.gov/Traces/sra). Fastq ﬁles were then processed as
previously described12. Brieﬂy, data were aligned using
bowtie213, and converted to bam, sorted and indexed
using SAMtools14. The resulting bam ﬁles for two biolo-
gical replicates for each cell type were merged using
BEDTools15 to produce single consolidated read sets for
NeuN-positive and NeuN-negative cell types. All four ﬁles
(two biological replicates for each cell type) were also
merged to produce an additional read set that mimicked
data generated from non-sorted post-mortem tissue,
hereafter called ‘reconstituted’ brain data set. Peaks were
called as previously described12 using broad peak calling
in MACS 2.016 with broad-cutoff= 0.1 and q-value=
0.01.
Aligned H3K3me3 ChIP-seq reads generated from
astrocytes6 were downloaded from GEO (GSM733747)
along with matched input samples (GSM733678). Peaks
were called for each replicate as described above. Peaks
with a negative log10 P-value of 5 or greater were retained
and the resulting peak ﬁles intersected using BEDTools15
produce a peak set used in further analysis.
H3K4me3 and input ChIP-sequencing data from
human adipocyte cells were downloaded from GEO series
GSE41629 and processed as described for the astrocytes,
with the exception that these data only consisted of a
single replicate. This peak set was used as a negative
control in the analysis to ensure results were speciﬁc to
the brain cell types of interest.
Cell-type speciﬁc peaks were extracted by intersecting
the appropriate processed bed ﬁles (e.g. NeuN-positive
peak ﬁle and NeuN-negative peak ﬁle) using BEDTools15.
GWAS summary statistics
Schizophrenia GWAS summary statistics were down-
load from https://www.med.unc.edu/pgc/results-and-
downloads. Data used were from the largest schizo-
phrenia GWAS undertaken to date that is publicly avail-
able, the Psychiatric Genomics Consortium’s 2014 study
(PGC-SCZ)1. The PGC-SCZ study included 79,845 indi-
viduals with a case control ratio of 0.429.
Partitioning heritability
Heritability was partitioned using LD score regression3
following previously described methodology4. Consistent
with previous partitioning heritability studies4, all peaks
were extended by ±500 base pairs. LD score ﬁles were
made for each speciﬁc annotation of interest using the
open source software available here: https://github.com/
bulik/ldsc/wiki. The major histocompatibility complex
(MHC) region was removed from the schizophrenia
GWAS summary statistics as was done in the original
analysis due to the LD structure of the region. Each
annotation was added to the baseline model
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independently creating 12 separate models, as was done in
the original analysis4. The baseline model includes 24
non-cell-speciﬁc annotations that cover a range of DNA
features, such as coding, three prime untranslated region,
promoter, intronic, H3K4me1 marks, H3K4me3 marks,
H3K9ac marks, H3K27ac marks, DNase I hypersensitivity
sites, chromHMM and Segway predictions, regions con-
served in mammals, super-enhancers, and FANTOM5
enhancers (please see ref. 4 for more information about
the baseline model). Z-scores were extracted from each
model for the annotation of interest and were used to
calculate P-values, hereafter called z-score P-values.
Additionally, we performed a conditional partitioned
heritability analysis. For this, we ran a model that included
both NeuN-positive and NeuN-negative H3K4me3
annotations along with the baseline, and another model
that included human stem cell-derived neurons and cul-
tured primary human astrocytes H3K4me3 annotations
along with the baseline.
We report the enrichment of schizophrenia heritability
within each cell-type speciﬁc functional category, as
enrichment is more easily understood and interpretable in
terms of the relationship between schizophrenia herit-
ability and cell-type speciﬁc functional categories than z-
scores. However, we report the z-score P-value alongside
these enrichments instead of the enrichment P-value as z-
score P-value controls for the overlap of cell-type-speciﬁc
annotations with other functional categories that are
included in the full baseline model4 or annotations
included in a conditional partitioned heritability analysis,
whereas enrichment P-values do not.
In total, we performed 12 tests of enrichment and two
conditional tests for a total of 14 tests. Using Bonferroni’s
correction for multiple testing, P-values below P< 3.57×
10−3 were considered to have withstood correction for
multiple testing.
Results
To conﬁrm the previously reported enrichment of
heritability at variants located in brain H3K4me3 sites4,
and to validate the post-mortem brain data used here, we
ﬁrst combined the NeuN-positive and NeuN-negative
H3K4me3 data to produce a ‘reconstituted’ brain data set.
We observed a signiﬁcant enrichment of heritability at
variants located in these regions (enrichment (SE)=
10.789 (1.221); z-score P= 7.37× 10−11; Table 1; Fig. 1),
with a similar magnitude and signiﬁcance as previously
reported for unsorted brain tissue4, conﬁrming the suit-
ability of these data for further analysis.
Next we used variants in H3K4me3 sites identiﬁed in
NeuN-positive and NeuN-negative cells separately to
investigate the relative contribution of each cell type to
schizophrenia risk. There was signiﬁcant enrichment of
heritability from variants located in H3K4me3 sites from
both cell populations (NeuN-positive enrichment (SE)=
15.178 (1.848); z-score P= 1.38× 10−10; NeuN-negative
enrichment (SE)= 9.674 (1.225); z-score P= 7.97×
10−10; Table 1; Fig. 1).
Given an enrichment of heritability was observed from
variants located in H3K4me3 sites in either cell popula-
tion, we investigated the contribution of variants located
in common and cell-type speciﬁc H3K4me3 sites. SNPs in
H3K4me3 marked regions that were shared between
neuronal (NeuN positive) and non-neuronal (NeuN-
negative) brain cells showed the most signiﬁcant enrich-
ment (enrichment (SE)= 14.455 (1.820); z-score P=
2.39× 10−12; Table 1; Fig. 1). However, a high level of
enrichment was also observed at SNPs located in
H3K4me3 regions speciﬁc to neuronal cells (NeuN posi-
tive) (enrichment (SE)= 22.476 (5.470); z-score P=
5.34× 10−4; Table 1; Fig. 1). In contrast, SNPs in non-
neuronal (NeuN negative) cell-speciﬁc H3K4me3 ele-
ments showed no signiﬁcant enrichment (enrichment
(SE)= 6.199 (1.961); z-score P= 0.097). A conditional
partitioned heritability analysis also conﬁrmed these
results with H3K4me3 regions in neuronal cells (NeuN
positive) remaining signiﬁcantly associated (z-score P=
3.60× 10−6) when H3K4me3 regions in non-neuronal
cells (NeuN negative) was included in the model, and
H3K4me3 regions in non-neuronal cells (NeuN negative)
did not remain associated (z-score P= 0.102) (Table 1).
This pattern of enrichment was replicated in cell culture
systems using human stem cell-derived neurons and
cultured primary human astrocytes. Consistent with the
results from sorted post-mortem brain, enrichment of
heritability was observed from SNPs located in neuronal
(enrichment (SE)= 7.436 (0.839); z-score P= 9.52×
10−12) and non-neuronal (enrichment (SE)= 6.766
(1.048); z-score P= 2.37× 10−5) H3K4me3 sites (Table 1;
Fig. 1). SNPs residing in H3K4me3 elements shared by
human stem cell-derived neurons and astrocytes were
also enriched (enrichment (SE)= 9.992 (1.393); z-score P
= 3.00× 10−8; Table 1; Fig. 1). In agreement with the
post-mortem cell-type-speciﬁc elements, SNPs residing in
H3K4me3 sites speciﬁc to human stem cell-derived neu-
rons were also signiﬁcantly enriched (enrichment (SE)=
7.122 (1.393); z-score P= 3.13× 10−4), while those SNPs
within H3K4me3 elements speciﬁc to astrocytes were not
(enrichment (SE)= 3.514 (1.749); z-score P= 0.470)
(Table 1; Fig. 1). Performing a conditional partitioned
heritability analysis resulted in a similar association pat-
tern with H3K4me3 regions in human stem cell-derived
neurons remaining signiﬁcantly associated (z-score P=
4.72× 10−8) when H3K4me3 regions in cultured primary
human astrocytes were included in the model, and
H3K4me3 regions in cultured primary human astrocytes
were only weakly associated (z-score P= 0.043) (Table 1).
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No signiﬁcant enrichment at SNPs located in
H3K4me3 sites identiﬁed in adipocytes, a negative control
tissue, was observed (enrichment (SE)= 3.691 (0.918); z-
score P= 0.070; Table 1), indicating enrichment speciﬁc
to brain cell types tested.
Discussion
Our analysis sought to investigate the relative con-
tribution of two major brain cell types, neurons and glia,
to genetic risk mechanisms for schizophrenia. Using
measurements of genome-wide partitioned heritability,
we ﬁnd that both neurons and glia are potential mediators
of genetic risk for schizophrenia. This ﬁnding is robust
across two distinct methods of cell separation, neuronal
cell sorting of post-mortem tissue and cultured cells.
However, variants in neuronal H3K4me3 marked regions
remained enriched after accounting for the contribution
of non-neuronal cells, indicating that the neuronal cell
populations may be more important. This pattern is also
consistent when considering cell-speciﬁc H3K4me3
marks; an enrichment in SNPs located within neuronal
speciﬁc but not non-neuronal H3K4me3 marks is
observed when using both post-mortem tissue and cul-
tured cells. The contribution of non-neuronal brain cell
types to schizophrenia pathology has been documented
previously17,18, but their role in primary pathobiological
mechanisms was unknown. Our results suggest that
genetic risk for schizophrenia plausibly acts, in part, via
direct disruption of glial cell function. However, common
genetic variant schizophrenia heritability is unlikely to be
mediated by regulatory elements that are speciﬁc to glial
cells, but instead operate via regulatory elements that are
common to both neurons and glia, or those that are
speciﬁc to neurons. Nevertheless, subsequent biological
investigations should consider the role of both neurons
and glia in schizophrenia pathobiology and treatment.
Although genomic studies of schizophrenia have iden-
tiﬁed robust risk loci, major challenges exist when
attempting to translate these ﬁndings into biological
mechanisms. For non-coding variation, which includes
Table 1 Results from the partitioned heritability analysis for the cell types tested for enrichment of SNPs within
H3K4me3 marks (a marker of active gene promoters)
Cell type Proportion of
SNPs
Proportion of h2
(SE)
Enrichment (SE) Enrichment P-
value
Z-score P-
value
‘Reconstituted’ brain (NeuN positive and NeuN
negative)
0.021 0.225 (0.025) 10.789 (1.221) 3.13 × 10−13 7.37 × 10−11
Neuronal (NeuN positive) 0.013 0.195 (0.024) 15.178 (1.848) 2.99 × 10−12 1.38 × 10−10
Non-neuronal (NeuN negative) 0.018 0.178 (0.023) 9.674 (1.225) 1.82 × 10−11 7.97 × 10−10
Common neuronal and non-neuronal (NeuN
positive and NeuN negative)
0.010 0.150 (0.019) 14.455 (1.820) 3.00 × 10−12 2.39 × 10−12
Neuronal speciﬁc (NeuN-positive only) 0.002 0.054 (0.013) 22.476 (5.470) 1.87 × 10−4 5.34 × 10−4
Non-neuronal speciﬁc (NeuN negative only) 0.008 0.050 (0.016) 6.199 (1.961) 8.43 × 10−3 0.097
Conditional analysis Neuronal (NeuN positive) 0.013 0.195 15.214 2.55 × 10−12 3.56 × 10−6
(0.024) (1.847)
Conditional analysis Non-neuronal (NeuN
negative)
0.018 0.189 (0.023) 10.291 (1.235) 1.41 × 10−12 0.102
Human ES-derived neurons 0.021 0.159 (0.018) 7.436 (0.839) 7.19 × 10−13 9.52 × 10−12
Astrocytes 0.017 0.118 (0.018) 6.766 (1.048) 9.68 × 10−8 2.37 × 10−5
Common human ES-derived neurons and
astrocyte
0.010 0.105 (0.015) 9.992 (1.393) 7.81 × 10−10 3.00 × 10−8
Human ES-derived neurons speciﬁc 0.011 0.077 (0.015) 7.122 (1.393) 1.66 × 10−5 3.13 × 10−4
Astrocytes speciﬁc 0.007 0.024 (0.012) 3.514 (1.749) 0.151 0.470
Conditional analysis Human ES-derived neurons 0.021 0.159 (0.018) 7.476 (0.838) 5.32 × 10−13 4.72 × 10−8
Conditional analysis Astrocytes 0.017 0.112 (0.018) 6.441 (1.054) 5.15 × 10−7 0.043
Adipocytes 0.025 0.092 (0.023) 3.691 (0.918) 3.73 × 10−3 0.070
h2 is the genetic heritability. SE is the standard error. Z-score P-values below the Bonferroni corrected P-value of P < 3.57 × 10−3 are shown in bold. ES, embryonic stem
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the majority of risk variants discovered by GWAS, this
includes identifying the tissue/cell types in which the
genetic variants exert their effect19. The tissue speciﬁcity
of non-coding elements, and by extension the effects of
variants in these elements, is deﬁned by post-translational
modiﬁcation of histones, chromatin structure and tran-
scription factor binding. The integration of genomic
ﬁndings with detailed maps of gene-regulatory elements
can therefore empirically determine the tissue and cells
types most relevant for disease risk. Similarly, integration
with expression and methylation quantitative trait loci has
been used to implicate brain active regulatory variants in
psychiatric disease risk mechanisms20,21. However, tissues
are comprised of a complex mix of cells, each with distinct
gene expression and regulatory DNA element repertoires.
The complex cellular composition of the human brain is
therefore a signiﬁcant barrier to the interpretation of non-
coding variant-mediated genetic mechanisms of neu-
ropsychiatric and neurodegenerative diseases. Without
detailed cell-type information our ability to produce valid
disease models and novel therapies is hampered.
Although our ﬁndings suggest that both neurons and glia
are potential mediators of genetic risk, it will be important
to investigate the contribution of cells types at a much
higher resolution than current data provided (e.g. indivi-
dual neuronal subtypes). Importantly, we show that the
use of sorted nuclei from post-mortem material and cell-
type-speciﬁc culture models are both likely to be useful
approaches for investigating the contribution of deﬁned
cell types to genetic risk mechanisms of schizophrenia.
Although we see strong agreement between results from
post-mortem tissue and in vitro systems, they do not
correspond to identical cell populations. Speciﬁcally, the
sorted post-mortem cell populations are likely to be more
heterogeneous than their cell culture counterparts. For
example, although the NeuN-negative cell population is
largely composed of astrocytes, mimicking the primary
cell culture system included in our analysis, it will also
contain other NeuN-negative cell types (e.g. microglia and
oligodendrocytes). Similarly, the NeuN-positive cell
population contains a mixture of neuronal subtypes that
are not likely be captured in the single-cell culture model
used here. These differences in cell composition, along
with other factors (e.g. immaturity of stem cell-derived
Fig. 1 Enrichment and −log10 P-value for the results of partitioned heritability analysis for SNPs within H3K4me3 marks (a marker of
active gene promoters) for the different cell types. . a Enrichment of schizophrenia heritability at H3K4me3 sites in post-mortem brain tissues. Y-
axis is the enrichment value and x-axis is the different cell types. b −log10 P-values for the enrichment of schizophrenia heritability at H3K4me3 sites
in post-mortem brain tissues. X-axis is the −log10 P-value derived from the z-score; y-axis is the different cell types. Red line is the signiﬁcance
threshold for a Bonferroni correction for multiple testing for total number of analyses undertaken (14 tests performed). c Enrichment of schizophrenia
heritability at H3K4me3 sites identiﬁed in cultured cells. Y-axis is the enrichment value and x-axis is the different cell types. d −log10 P-values for
enrichment of schizophrenia heritability at H3K4me3 sites identiﬁed in cultured cells. X-axis is the −log10 P-value derived from the z-score; y-axis is
the different cell types Red line is the signiﬁcance threshold for a Bonferroni correction for multiple testing for total number of analyses undertaken
(14 tests performed)
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neurons), may underlie the larger enrichments observed
when using post-mortem brain tissue compared with cell
culture systems.
Improved methods for the selective isolation of cell
populations from post-mortem brain tissue22, along with
directed differentiation of human stem cells, will be
powerful tools for investigating the regulatory landscape
of human brain cells. Subsequent integration with disease
genomics promises to identify speciﬁc risk loci acting in
deﬁned cells types that will aid in our biological under-
standing of disease risk mechanisms.
In summary, using measurements of partitioned herit-
ability, we show that common variant schizophrenia
heritability is signiﬁcantly enriched within H3K4me3
marked regions identiﬁed in neuronal and non-neuronal
cell populations of the human post-mortem brain. This
ﬁnding is replicated using data from tissue culture sys-
tems, where cell types can be differentiated and grown in
isolation. Together, these results show that schizophrenia
genetic risk mechanisms potentially operate in both
neuronal and non-neuronal cells of the brain. However,
the greatest enrichment arises from the neuronal cell
population, as well as from neuronal-speciﬁc regulatory
elements. Strong agreement between results from post-
mortem cell types and cell culture systems validate
in vitro systems as tools for studying genetic risk
mechanisms of schizophrenia. Future investigations of
gene-regulatory landscapes using deﬁned cell types, either
from post-mortem tissue or from in vitro models, will
further our understanding of schizophrenia genetic risk
mechanisms.
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